A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI

Clinical trial NCT01763307 · COMPLETED

Trial details

NCT number: NCT01763307
Sponsor: Hadassah Medical Organization
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rash Due to Epidermal Growth Factor Receptor Inhibitors

Start date: 2013-01-01
Primary completion: 2014-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.